tradingkey.logo


tradingkey.logo


Nasus Pharma Ltd

NSRX

詳现チャヌトを衚瀺
5.440USD
-0.550-9.18%
終倀 02/06, 16:00ET15分遅れの株䟡
49.28M時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

-9.18%

5日間

-5.23%

1ヶ月

-27.47%

6ヶ月

0.00%

幎初来

-40.55%

1幎間

0.00%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Nasus Pharma Ltd ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Nasus Pharma Ltdの䌁業情報

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
䌁業コヌドNSRX
䌁業名Nasus Pharma Ltd
最高経営責任者「CEO」Teleman (Dan)
りェブサむトhttps://www.nasuspharma.com
KeyAI
î™